Concepedia

Michal Weingart

MW

6

Publications

586

Citations

6

H-Index

2005

Active since

Affiliations

Intra Cellular Therapies (United States)(Current)

Zucker Hillside Hospital

Michal Weingart is an author at Intra Cellular Therapies (United States) specializing in medicine, drug discovery, and schizophrenia.

Top concepts

Publications per year

2005–2020

6

Publications

6

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia

Christoph U. Correll, Robert E. Davis, Michal Weingart et al. · JAMA Psychiatry · 2020 · 276 citations · Full text

Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Kimberly E. Vanover, Robert E. Davis, Yun Zhou et al. · Neuropsychopharmacology · 2018 · 236 citations · Full text

Fungal Types and Concentrations from Settled Dust in Normal Residences

Jeffrey B. Hicks, Elizabeth T. Lu, Rachel De Guzman et al. · Journal of Occupational and Environmental Hygiene · 2005 · 34 citations

, , +17

S44. LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY

Kimberly E. Vanover, Alex Dmitrienko, Steven Glass et al. · Schizophrenia Bulletin · 2018 · 17 citations · Full text

, , +15

S117. FAVORABLE LONG-TERM SAFETY PROFILE OF LUMATEPERONE IITI-007): RESULTS FROM A 12 MONTH OPEN LABEL SAFETY STUDY FOR LUMATEPERONE IN PATIENTS WITH STABLE SYMPTOMS OF SCHIZOPHRENIA

Kimberly E. Vanover, Andrew Satlin, Saresh Durgam et al. · Schizophrenia Bulletin · 2019 · 12 citations · Full text

Rows per page

1–5 of 6